# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Extrahepatic bile duct cancer

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 42 results.
Prospective Evaluation of the Ablation Therapy With Bipolar Radio Frequency for Nonresectable Bile Duct Cancer
Status: Recruiting
Last Changed: Sep 20, 2018
First Received: Sep 20, 2018
Disease(s): Nonresectable Bile Duct Cancer
Intervention(s): Ablation Therapy
Locations: Institut Paoli-Calmettes, Marseille, France
Safety and Efficacy of Modified Folfirinox Versus Gemcis in Bile Duct Tumours
Status: Recruiting
Last Changed: Oct 29, 2018
First Received: Oct 29, 2015
Disease(s): Bile Duct Cancer
Intervention(s): GEMCIS, mFolfirinox
Locations: Chu Picardie, Amiens, France
Ico Paul Papin, Angers, France
CH Victor Dupouy, Argenteuil, France
CH de la Côte Basque, Bayonne, France
CHRU Besançon, Besançon, France
... and 38 other locations.
Development of a New Immunochemistry Method Using Antibodies of Proteins Related Bile Duct Cancer
Status: Recruiting
Last Changed: Jan 08, 2019
First Received: Oct 17, 2018
Disease(s): Bile Duct Obstruction, Extrahepatic
Intervention(s): Cytology staining
Locations: CHA Bundang Medical Center, Seongnam, Bundang-gu, Korea, Republic of
Gangnam Severance Hospital, Seoul, Gangnam-gu, Korea, Republic of
In Ha University Hospital, Incheon, Jung-gu, Korea, Republic of
Soon Chun Hyang University Hospital, Cheonan, Cheonan, Namdong-gu, Korea, Republic of
Gachon University Gil Medical Center, Incheon, Namdong-gu, Korea, Republic of
... and 2 other locations.
Safety and Tumoricidal Effect of Low Dose Foscan PDT in Patients With Inoperable Bile Duct Cancers
Status: Recruiting
Last Changed: Jul 18, 2018
First Received: Dec 26, 2016
Disease(s): Cholangiocarcinoma, Tumor, Klatskin Tumor
Intervention(s): Temoporfin
Locations: Endoscopy Centre, Prince of Wales Hospital, Shatin, N.t., Hong Kong
Comparison Between Volatile Anesthetic-desflurane and Total Intravenous Anesthesia With Propofol and Remifentanil on Early Recovery Quality and Long Term Prognosis of Patients Undergoing Pancreatic Cancer and Common Bile Duct Cancer Surgery
Status: Recruiting
Last Changed: Jan 11, 2019
First Received: Feb 27, 2018
Disease(s): Pancreatic Cancer or Distal CBD Cancer
Intervention(s): Des (volatile anesthetic-desflurane), TIVA (Total intravenous anesthesia with propofol and remifentanil)
Locations: Department of Anesthesiology and Pain Medicine Anesthesia and Pain Research Institute Yonsei University College of Medicine, Seoul, Korea, Republic of
Percutaneous Hepatic Perfusion vs. Cisplatin/Gemcitabine in Patients With Intrahepatic Cholangiocarcinoma
Status: Recruiting
Last Changed: Jul 19, 2018
First Received: Mar 22, 2017
Disease(s): Bile Duct Cancer, Intrahepatic Cholangiocarcinoma
Intervention(s): Melphalan/HDS, Cisplatin and Gemcitabine
Locations: Duke Health, Durham, North Carolina, United States
Ohio State University/Teaching Hospital, Columbus, Ohio, United States
West Cancer Center, Memphis, Tennessee, United States
Metal Stents (Moving Cell Stent) for Inoperable Tumors of the Bile Duct Tract
Status: Recruiting
Last Changed: Dec 27, 2018
First Received: Dec 27, 2018
Disease(s): Bile Duct Stricture, Bile Duct Cancer
Locations: Klinikum der J. W. Goethe-Universität, Frankfurt am Main, Germany
PTFE Stents for Treatment of Malignant Biliary Strictures
Status: Recruiting
Last Changed: Dec 04, 2018
First Received: Dec 04, 2018
Disease(s): Bile Duct Stricture, Bile Duct Cancer, Pancreas Cancer
Intervention(s): Stenting with PTFE-coated stent (HILZO)
Locations: Klinikum der J. W. Goethe-Universität, Frankfurt am Main, Germany
Treatment for Bile Duct Cancer in the Liver
Status: Recruiting
Last Changed: Feb 26, 2019
First Received: Jun 19, 2014
Disease(s): Cholangio Carcinoma
Intervention(s): SIRT Yttrium-90
Locations: Department of Clinical Oncology, Prince of Wales Hospital, Hong Kong, Hong Kong
RFA RCT for Pancreatic or Bile Duct Cancer
Status: Recruiting
Last Changed: Mar 30, 2018
First Received: Jun 18, 2014
Disease(s): Unresectable Pancreatic Cancer, Cholangiocarcinoma Non-resectable
Intervention(s): Radiofrequency Ablation using EndoHPB Probe, Stenting only
Locations: Weill Cornell Medical College, New York, New York, United States